Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics.BMC medical ethics · 2022
   Article
2. COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations.Clinical journal of oncology nursing · 2022
   Article
3. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.Translational research : the journal of laboratory and clinical medicine · 2022
   Review
4. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.Future oncology (London, England) · 2022
   Article
5. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain.International journal of cancer · 2022
   Article
6. Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.Therapeutic advances in medical oncology · 2022
   Article
7. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.Blood cancer journal · 2021
   Article
8. Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.Current treatment options in oncology · 2021
   Review

Corrections and comments

• Comment on
  Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.2021
• Comment on
  Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.2021

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as